EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ibogalogs induce antiseizure activity in rodents by a mechanism involving 5-HT2A/2C receptor activation with a major role of 5-HT2A receptors in the hippocampal CA3 subfield

Abdeslam Chagraoui, Paulina Kazmierska-Grebowska, Olivia Byache, Alejandro Abraham, Deborah Rudin, Bartosz Caban, Tomasz Kowalczyk, Matthias E Liechti, Daniel Wacker, Chloé Aman, Philippe De Deurwaerdère, Hugo R Arias

Biochemical Pharmacology · 2026

DOI: 10.1016/j.bcp.2026.117799 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026. Verfasst von Abdeslam Chagraoui und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Nordic: Neuroendocrine, endocrine and germinal differentiation communication - UMR 1239 (Inserm), Normandy University, UNIROUEN, Institute…. Hauptthemen laut MEDLINE: Receptor, Serotonin, 5-HT2A, Receptor, Serotonin, 5-HT2C, Anticonvulsants, Seizures. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institutes of Health, Ohio State University Press.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The antiseizure properties of ibogalogs, including ibogaminalog (DM506), ibogainalog (IBG), and nor-IBG, were assessed in rodents using the pentylenetetrazol (PTZ)-induced seizure test. The behavioral findings indicated that ibogalogs exhibited mild acute antiseizure effects in mice, with endpoint- and time window-dependent differences between the compounds. The antiseizure effect was suppressed by volinanserin and SB242084, consistent with the involvement of 5-HT2A and 5-HT2C receptors. The antiseizure activity after repeated administration (7 and 14 days) of subthreshold doses of nor-IBG (3 mg/kg) or DM506 (5 mg/kg) was higher than that after acute treatment, indicating augmented efficacy. Subthreshold doses of DM506 and nor-IBG restored the impact of PTZ on monoamine levels in hippocampal tissue following repeated administration, but not after a single dose. Additionally, the influence of ibogalogs was evaluated on epileptiform discharges induced by kainic acid (KA) in the CA3 region of the hippocampus. The results showed that nor-IBG and DM506 decreased epileptiform discharges in a concentration-dependent manner. Nor-IBG activity was inhibited by volinanserin, supporting a role for the 5-HT2AR. Functional studies have shown that ibogalogs are more potent agonists at 5-HT2A/2CRs than at 5-HT1A/1BRs, supporting the role of 5-HT2AR. In conclusion, repetitive treatment with ibogalogs induced antiseizure activity in mice through 5-HT2A/2CR activation, accompanied by normalization of PTZ-induced alterations in hippocampal monoamines. In the hippocampal CA3 subfield, ibogalogs reduced KA-induced epileptiform discharges, where nor-IBG activity was mediated by 5-HT2AR activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Serotonin, 5-HT2AReceptor, Serotonin, 5-HT2CAnticonvulsantsSeizuresCA3 Region, HippocampalAnimalsMaleMiceSerotonin 5-HT2 Receptor AgonistsDose-Response Relationship, Drug

Stichwörter der Autor:innen

5-HT(2A/2C)receptorsAntiseizure activityIbogalogsKainic acidMonoamines

Substanzen

Receptor, Serotonin, 5-HT2AReceptor, Serotonin, 5-HT2CAnticonvulsantsSerotonin 5-HT2 Receptor Agonists

Autor:innen und Institutionen

  • Laboratory Nordic: Neuroendocrine, endocrine and germinal differentiation communication - UMR 1239 (Inserm), Normandy University, UNIROUEN, Institute for Research and Innovation in Biomedicine of Normandy (IRIB), Rouen,…
  • Department of Neurobiology, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland.
  • Centre National de la Recherche Scientifique, Institut des Neurosciences Intégratives et Cognitives d'Aquitaine, UMR 5287, Bordeaux, France.
  • Department of Pharmacological Sciences and Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Division of Clinical Pharmacology and Toxicology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland; Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University H…
  • Department of Pharmacology and Physiology, Oklahoma State University College of Osteopathic Medicine, Tahlequah, OK, USA.

Förderung

  • NIGMS NIH HHS
  • National Institutes of Health
  • Ohio State University Press
  • National Science Centre Poland

Zitieren

APA

Chagraoui, A., Kazmierska-Grebowska, P., Byache, O., Abraham, A., Rudin, D., Caban, B., Kowalczyk, T., Liechti, M. E., Wacker, D., Aman, C., Deurwaerdère, P., & Arias, H. R. (2026). Ibogalogs induce antiseizure activity in rodents by a mechanism involving 5-HT2A/2C receptor activation with a major role of 5-HT2A receptors in the hippocampal CA3 subfield. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2026.117799

Vancouver

Chagraoui A, Kazmierska-Grebowska P, Byache O, Abraham A, Rudin D, Caban B, et al. Ibogalogs induce antiseizure activity in rodents by a mechanism involving 5-HT2A/2C receptor activation with a major role of 5-HT2A receptors in the hippocampal CA3 subfield. Biochemical Pharmacology. 2026. doi:10.1016/j.bcp.2026.117799

BibTeX
@article{Chagraoui2026,
  author = {Chagraoui, Abdeslam and Kazmierska-Grebowska, Paulina and Byache, Olivia and Abraham, Alejandro and Rudin, Deborah and Caban, Bartosz and Kowalczyk, Tomasz and Liechti, Matthias E and Wacker, Daniel and Aman, Chloé and Deurwaerdère, Philippe De and Arias, Hugo R},
  title = {Ibogalogs induce antiseizure activity in rodents by a mechanism involving 5-HT2A/2C receptor activation with a major role of 5-HT2A receptors in the hippocampal CA3 subfield},
  journal = {Biochemical Pharmacology},
  year = {2026},
  doi = {10.1016/j.bcp.2026.117799}
}
Kostenlos starten →